The Statutory Framework of RSA 77-E:3-b: Strategic Application of the New Hampshire Research and Development Tax Credit

RSA 77-E:3-b provides the statutory mechanism allowing New Hampshire businesses to apply unused research and development tax credits against their Business Enterprise Tax liability. This provision ensures that innovative manufacturing firms can maximize their tax relief by offsetting payroll-based taxes after first reducing their business profits tax obligations.

The implementation of RSA 77-E:3-b represents a critical intersection within the dual-taxation environment of the Granite State. New Hampshire maintains a unique business tax structure comprising the Business Profits Tax (BPT), established under RSA 77-A, and the Business Enterprise Tax (BET), established under RSA 77-E.1 While the research and development (R&D) credit is fundamentally authorized and defined within the BPT framework via RSA 77-A:5, XIII, the specific language of RSA 77-E:3-b serves as the legal “bridge” that permits the cross-application of these credits.3 This architecture is designed to support the state’s manufacturing sector, ensuring that investment in high-value labor yields fiscal benefits even when a company has not yet achieved significant taxable net income. In professional practice, understanding the nuance of this section is essential for navigating the complexities of New Hampshire’s corporate tax obligations, particularly for entities in the life sciences, technology, and advanced machinery sectors.5

Legislative Evolution and the Genesis of RSA 77-E:3-b

The history of RSA 77-E:3-b is inseparable from the broader efforts of the New Hampshire General Court to incentivize industrial innovation. The research and development tax credit was first established during the 2007 legislative session through Senate Bill 134, codified as Chapter 271 of the Laws of 2007.3 At its inception, the legislature recognized that the existing Business Profits Tax was insufficient as a standalone vehicle for incentives, as many emerging technology firms operated with high overhead and significant research payroll but minimal taxable profits. To remedy this, the legislature simultaneously enacted RSA 77-E:3-b to allow the credit to flow into the Business Enterprise Tax, which is assessed on a much broader base including compensation, interest, and dividends.2

Initially, the program was launched with a modest $1,000,000 annual aggregate cap for all taxpayers combined, a figure intended to test the fiscal impact of the credit on state revenues.6 Technical Information Release (TIR) 2007-007 provided the first set of comprehensive guidance, clarifying that the credit must first be applied against the BPT, with only the “remainder” eligible for application against the BET under the newly created 77-E:3-b.6 This established a hierarchy of tax relief that remains the standard today.

As the state’s technology and manufacturing sectors expanded, particularly the life sciences hub in the southern tier, the legislature moved to increase the program’s capacity. In 2013, Senate Bill 1 (Chapter 5, Laws of 2013) doubled the annual aggregate award to $2,000,000 and repealed the sunset provision that had previously threatened the credit’s permanence.8 The most significant expansion occurred in 2015, when House Bill 2 (Chapter 276, Laws of 2015) increased the aggregate cap to the current $7,000,000, effective July 1, 2017.3 This legislative trajectory underscores a persistent commitment to the manufacturing sector, positioning RSA 77-E:3-b as a cornerstone of the state’s economic development strategy.

*Proposed legislation currently under review as of early 2025.9

The Dual-Tax Mechanism: BPT vs. BET Context

To comprehend the application of RSA 77-E:3-b, one must distinguish between the two primary business taxes in New Hampshire. The Business Profits Tax (BPT) is a tax on income from all business activity within the state. As of 2024, the BPT rate has been reduced to 7.6% for taxable periods ending on or after December 31, 2022.11 The BPT applies to business organizations with gross business income exceeding $103,000.7

Conversely, the Business Enterprise Tax (BET) is an “enterprise value tax,” which is fundamentally different from an income tax. The BET is assessed at a rate of 0.55% on the “enterprise value tax base,” defined as the sum of all compensation paid or accrued, interest paid or accrued, and dividends paid by the business organization.2 The BET is applicable to businesses with gross receipts exceeding $281,000 or an enterprise value tax base exceeding $281,000.7 Because the BET captures payroll expenses regardless of profitability, it often represents a significant liability for R&D-heavy firms that employ high-salaried engineers and scientists but have not yet achieved a net profit. This is precisely where RSA 77-E:3-b becomes the primary mechanism for relief.

The interplay between these taxes is governed by a sequencing rule: the R&D credit is always a BPT-first credit. A taxpayer cannot choose to apply the credit to the BET if a BPT liability exists. The statutory language and administrative guidance under Rev 2406.05 require that the credit be used to offset the taxpayer’s BPT liability for the taxable period first.6 Only after the BPT has been reduced to zero can the excess credit be applied to the BET under RSA 77-E:3-b.8 This ensures that the state’s primary corporate income tax is settled before the broader-based enterprise tax is impacted.

Qualifying for the Credit: The Manufacturing Requirement

The New Hampshire R&D credit is significantly more specialized than the federal research credit under Internal Revenue Code (IRC) Section 41. While the federal credit allows for various expenses, including supplies, contract research, and computer leasing, the New Hampshire credit—and by extension the offset permitted by RSA 77-E:3-b—is strictly limited to “qualified manufacturing research and development expenditures”.15

The state defines these expenditures exclusively as wages paid to employees of the business organization for services rendered in New Hampshire.8 These wages must meet the federal standards for qualified research but must be specifically attributable to manufacturing activities within the state. In practice, the Department of Revenue Administration (DRA) instructs taxpayers that qualifying expenditures are those wage amounts attributable to New Hampshire that constitute lines 5 or 24 of the business organization’s Federal Form 6765.8

The manufacturing nexus is a critical area of focus for state auditors. To be considered “manufacturing research,” the activities must relate to the development of new or improved products or processes in an industrial or technological context. The exclusion of non-manufacturing research—such as purely software-based services that do not involve a manufactured component or process—makes the New Hampshire credit a highly targeted incentive for the state’s industrial core.15

The Four-Part Federal Test for Wages

Although New Hampshire restricts the credit to wages, those wages must still pass the federal “four-part test” to be eligible for the credit applied via RSA 77-E:3-b:

1. Elimination of Uncertainty: The activity must be intended to discover information that would eliminate uncertainty regarding the development or design of a product or process.
2. Process of Experimentation: The taxpayer must evaluate alternatives through modeling, simulation, or systematic trial and error.
3. Technological in Nature: The research must rely on principles of physical science, biological science, engineering, or computer science.
4. Qualified Purpose: The research must relate to a new or improved function, performance, reliability, or quality of a business component.

Failure to meet any of these criteria for the underlying labor results in the disqualification of those wages from the credit calculation, regardless of their manufacturing context.

Calculation Methodology: Excess over Base

The credit authorized by RSA 77-E:3-b is calculated as 10% of the “excess” of the qualified manufacturing R&D expenses for the taxable year over the “base amount”.3 New Hampshire utilizes the regular incremental method for this calculation, following federal IRC § 41 rules for the base amount determination. This generally involves a fixed-base percentage multiplied by the average gross receipts for the prior four years.15

However, a distinctive feature of the New Hampshire calculation is the state’s treatment of the minimum base amount. While federal law mandates a minimum base of at least 50% of current-year research expenses, New Hampshire allows the base amount to be as low as $0.15 This provides a significant advantage for startups and rapidly growing companies. For example, a “start-up” company (defined as having fewer than three years of both gross receipts and QREs) uses a fixed-base percentage of 3% for its first five years, which gradually phases up to 16% by the tenth year.15

The maximum individual award is currently capped at $50,000 per fiscal year.3 If a business organization calculates a 10% credit that exceeds this amount, it must limit its request on Form DP-165 to $50,000. Furthermore, because the program is subject to a $7,000,000 aggregate statewide cap, all individual awards are subject to proportional reduction—or proration—if total valid requests exceed the pool.6

Local Revenue Office Guidance: The Application and Award Process

The New Hampshire Department of Revenue Administration (DRA) maintains strict administrative control over the R&D credit program. Unlike many other state tax credits that are claimed at the time of filing, the R&D credit must be approved prior to use. This multi-step process is vital for the correct application of RSA 77-E:3-b.

The June 30 Application Deadline

Taxpayers must submit Form DP-165, the “Research & Development Tax Credit Application,” no later than June 30 following the taxable period in which the expenses were incurred.3 The application must include a copy of the taxpayer’s Federal Form 6765. If the business is filing on a federal extension, a pro-forma or draft version of the Form 6765 is acceptable and required.8 The DRA emphasizes that late or incomplete applications will be rejected, and the taxpayer will be ineligible for a credit for that fiscal year.

The Proration Factor Mechanism

Because the credit is oversubscribed, the $7,000,000 cap is frequently a limiting factor. The DRA follows a specific procedure to manage this:

1. Application Review: The DRA verifies the eligibility of all wages and calculations submitted by the June 30 deadline.
2. Aggregate Calculation: The Department sums all approved credits from all taxpayers.
3. Proportional Reduction: If the sum exceeds $7,000,000, the DRA reduces each taxpayer’s share proportionally.6
4. Award Notification: By September 30, the DRA notifies all applicants by mail of their final award amount.8

Only after receiving this official award letter may the business organization claim the credit on its business tax returns. The award must be used within the subsequent five tax years following the period in which the expenditures were made.3

Administrative Sequencing and Form DP-160

The practical application of RSA 77-E:3-b is managed through Form DP-160, the “Schedule of Credits.” The instructions for this form clarify how the credit flows between the BPT and the BET. Section C of Form DP-160 is dedicated specifically to the Research & Development Tax Credit and provides the following steps:

1. Line 1: The taxpayer enters the total R&D credit amount awarded by the DRA.14
2. Line 2: The taxpayer enters the amount of the awarded credit used to offset the current period’s Business Profits Tax (BPT).14
3. Line 3: The taxpayer reports any “remaining” R&D credit not used in Line 2 to be used against the Business Enterprise Tax (BET) under RSA 77-E:3-b.14
4. Line 4: The sum of Lines 2 and 3 represents the total R&D credit used in the current period.
5. Line 5: Any excess (Line 1 minus Line 4) is recorded as the remaining credit available for future carryforward.14

This structured approach ensures that the credit is applied in the correct statutory order. The amount from Section C, Line 3 is then transferred to Section A of Form DP-160, which summarizes all credits applied to the BET.14

The “Non-Cascading” Status of the R&D Credit

A sophisticated nuance of RSA 77-E:3-b is its classification as a “non-cascading” credit. In the New Hampshire tax code, a cascading credit is one where the amount of credit applied to the Business Enterprise Tax is still considered “BET paid” for the purpose of the Business Profits Tax credit under RSA 77-A:5, X.2

According to the DRA’s Tax Expenditure and Potential Liability Report, the R&D credit does not cascade.2 This means that if a company uses $10,000 of R&D credits to pay its BET liability under RSA 77-E:3-b, that $10,000 is not available as a credit against its BPT. This stands in contrast to the Economic Revitalization Zone (ERZ) Tax Credit and the Coos County Job Creation Tax Credit, both of which are cascading credits.2

The rationale for this non-cascading status is to prevent a single incentive from eroding the state’s tax base twice. Because the R&D credit is already generous and subject to a specific aggregate cap, the legislature has limited its impact on the BET-to-BPT credit link. For tax planners, this means the R&D credit is less “valuable” per dollar than a cascading credit like the ERZ credit, as it does not generate a secondary tax benefit.2

Strategic Considerations for Combined Groups

For business organizations that are members of a “water’s edge” combined group, the application of RSA 77-E:3-b becomes significantly more complex. Under New Hampshire Code of Admin. Rules Rev 306.06, credits must be calculated and applied at the entity level.14

When a combined filer claims the R&D credit, and more than one member of the group is subject to the BPT, a separate schedule must be filed with Form DP-160 to show the calculations for each individual member.14 This is particularly relevant when one member of the group—perhaps a manufacturing subsidiary—conducts all the R&D, while other members handle distribution or administration. The manufacturing member’s R&D credit would first offset its own portion of the group’s BPT liability. Only then could the excess be used to offset that same member’s BET liability under RSA 77-E:3-b.14

The Department of Revenue Administration requires that the sequence of names and taxpayer identification numbers (TINs) remain consistent on all filings to ensure that the credits are applied to the correct accounts within the combined group.14 Misalignment of these identifiers can result in the loss of credit application or significant delays in processing.

Illustrative Case Study: Advanced Robotics NH, Inc.

To clarify the mechanics of RSA 77-E:3-b, consider the hypothetical scenario of “Advanced Robotics NH, Inc.,” a manufacturer of specialized industrial robots based in Nashua.

Step 1: Qualified Expenditure Identification

In the 2024 tax year, the company employs ten engineers dedicated to manufacturing research. Their combined wages for work performed in New Hampshire total $1,500,000. The company’s base amount, calculated using its historical gross receipts and research ratios, is $1,000,000.

• Qualified Wages: $1,500,000
• Base Amount: $1,000,000
• Excess: $500,000

Step 2: Preliminary Credit Calculation

The company calculates 10% of the excess:

$$0.10 \times \$500,000 = \$50,000$$

Because the preliminary credit is exactly $50,000, it meets but does not exceed the individual taxpayer cap.15

Step 3: Application and Proration

Advanced Robotics files Form DP-165 by June 30. The DRA later notifies the company that because total statewide requests were $8.5 million against a $7 million pool, all awards are prorated to approximately 82.35%.

• Awarded Credit: $\$50,000 \times 0.8235 = \$41,175$

Step 4: Tax Application (The RSA 77-E:3-b Offset)

The company determines its final tax liabilities for the period:

• BPT Liability: $10,000
• BET Liability: $40,000

Following the sequencing rules:

1. BPT Application: The first $10,000 of the credit is used to reduce the BPT liability to $0.
2. RSA 77-E:3-b Offset: The remaining $\$41,175 – \$10,000 = \$31,175$ is applied against the BET liability.
3. Final Tax Due: The company pays $\$40,000 – \$31,175 = \$8,825$ in Business Enterprise Tax.

Because the credit is non-cascading, the $31,175 applied to the BET is not considered “BET paid” and cannot be used to further reduce any future BPT.2

Statistical Overview of Program Performance

The New Hampshire R&D tax credit program has seen consistent growth and oversubscription since its inception. Data from the 2024 Tax Expenditure and Potential Liability Report and legislative analysis for SB 276 reveal the following statistics:

• Total Applicants: Since the program’s launch in 2008, 3,095 unique applicants have been awarded credits.5
• Oversubscription Rate: In recent years, approved ventures have requested credits exceeding the $7,000,000 cap by as much as $4,000,000 annually.5
• Economic Impact of Target Sector: The life sciences industry, a primary beneficiary of the credit, contributes $2.8 billion to New Hampshire’s GDP and supports over 11,000 high-paying jobs.5
• Concentration of Benefits: The $50,000 individual cap ensures that the $7,000,000 pool is distributed among a broad range of small and mid-sized manufacturers, preventing large conglomerates from exhausting the entire fund.15

Proposed Legislative Enhancements (2025-2026)

As of early 2025, the New Hampshire Senate is considering SB 276, a bill that would significantly alter the impact of RSA 77-E:3-b by increasing the available credit pool. The proposed legislation seeks to:

1. Increase the aggregate statewide cap from $7,000,000 to $10,000,000 per fiscal year.9
2. Increase the individual entity cap from $50,000 to $100,000.9

The Department of Revenue Administration’s fiscal note for SB 276 suggests that these changes would result in a $3,000,000 decrease in state business tax revenue in the first year of implementation, with the impact being distributed between the BPT and the BET via the RSA 77-E:3-b offset.9 Supporters of the bill, including NH Life Sciences, argue that the current caps have been stagnant for eight years, leading to a “rationing” of the credit that makes New Hampshire less competitive than neighboring states.5

Compliance and Audit Risks

The cross-application of credits to the Business Enterprise Tax via RSA 77-E:3-b is a focal point for DRA audits. Because the credit is limited to wages, auditors frequently review the “nexus” between the research activity and the manufacturing process.

Common Audit Triggers

• Non-Manufacturing Activity: Claiming credits for research related to purely administrative software or non-industrial service processes.15
• Remote Employee Wages: Including wages for R&D employees who reside and work outside of New Hampshire.8
• Inconsistent Compensation Definitions: Using a definition of “wages” for the R&D credit that does not match the “compensation” element reported on the BET return.13
• Improper Sequencing: Applying the credit to the BET before fully exhausting the BPT liability, or failing to file Form DP-160.14

The DRA maintains a three-year statute of limitations for auditing business tax returns, although this may be extended in cases of substantial underreporting or fraud.15 Taxpayers utilizing RSA 77-E:3-b are advised to maintain “project-level” documentation, including time-tracking records that tie specific employee labor to qualifying manufacturing R&D projects.

Conclusion: Strategic Value of RSA 77-E:3-b

RSA 77-E:3-b is more than a simple tax provision; it is the operational heart of New Hampshire’s industrial incentive policy. By permitting the R&D tax credit to bridge the gap between the Business Profits Tax and the Business Enterprise Tax, the state provides a robust safety net for innovative firms regardless of their immediate bottom-line profitability. For the manufacturing and life sciences sectors, this offset to the payroll-based BET is a vital tool for managing cash flow and subsidizing the high cost of specialized labor.

However, the effectiveness of RSA 77-E:3-b is constrained by the strict “wages-only” definition of qualified expenditures, the non-cascading nature of the credit, and the inevitable proration caused by the $7,000,000 aggregate cap. For business owners and tax professionals, the key to maximizing this benefit lies in meticulous compliance with the June 30 application deadline and a sophisticated understanding of the sequential application rules on Form DP-160. As the legislature considers expanding the program’s funding to $10,000,000, the importance of RSA 77-E:3-b as a driver of Granite State innovation is only expected to grow.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/